DOI QR코드

DOI QR Code

Korean Red Ginseng Induced Cardioprotection against Myocardial Ischemia in Guinea Pig

  • Lim, Kyu Hee (Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Kang, Chang-Won (Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University) ;
  • Choi, Jin-Yong (Department of Neurology, Medical School, Konkuk University) ;
  • Kim, Jong-Hoon (Department of Veterinary Physiology, College of Veterinary Medicine, Biosafety Research Institute, Chonbuk National University)
  • Received : 2013.02.14
  • Accepted : 2013.07.02
  • Published : 2013.08.30

Abstract

This study was designed to evaluate the protective effect of Korean red ginseng (KRG) against ischemia/reperfusion (I/R) injury in isolated guinea pig heart. KRG has been shown to possess various ginsenosides, which are the major components of Panax ginseng. These components are known naturally occurring compounds with beneficial effects and free radical scavenging activity. The heart was induced to ischemia for 60 min, followed by 120 min reperfusion. The hearts were randomly allocated into five groups (n=8 for each group): normal control (N/C), KRG control, I/R control, 250 mg/kg KRG group and 500 mg/kg KRG group. KRG significantly increased hemodynamics parameters such as aortic flow, coronary flow and cardiac output. Moreover, KRG significantly increased left ventricular systolic pressure (LVSP), the maximal rate of contraction (+dP/$dt_{max}$) and maximal rate of relaxation (-dP/$dt_{max}$). Also, treatment of KRG ameliorated electrocardiographic index such as the QRS, QT and RR intervals. Moreover, KRG significantly suppressed the lactate dehydrogenase, creatine kinase-MB fraction and cardiac troponin I and ameliorated the oxidative stress markers such as malondialdehyde and glutathione. KRG was standardized through ultra performance liquid chromatograph analysis for its major ginsenosides. Taken together, KRG has been shown to prevent cardiac injury by normalizing the biochemical and oxidative stress.

Keywords

References

  1. Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther. 2001;89:187-206. https://doi.org/10.1016/S0163-7258(00)00114-5
  2. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88:581-609. https://doi.org/10.1152/physrev.00024.2007
  3. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992; 26:101-108. https://doi.org/10.1093/cvr/26.2.101
  4. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg. 1999;68:1898-1904. https://doi.org/10.1016/S0003-4975(99)01035-8
  5. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B, Yau TM. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation. 2002;105:2332- 2336. https://doi.org/10.1161/01.CIR.0000016602.96363.36
  6. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation. 2008; 117:598-604. https://doi.org/10.1161/CIRCULATIONAHA.107.705947
  7. Luepker RV. Decline in incident coronary heart disease: why are the rates falling? Circulation. 2008;117:592-593. https://doi.org/10.1161/CIRCULATIONAHA.107.747477
  8. Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2005;14:170-175. https://doi.org/10.1016/j.carpath.2005.03.006
  9. Kim JH. Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res. 2012;36:16-26. https://doi.org/10.5142/jgr.2012.36.1.16
  10. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of indian plants for biological activity: I. Indian J Exp Biol. 1968;6:232-247.
  11. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the zutphen elderly study. Lancet. 1993;342:1007-1011. https://doi.org/10.1016/0140-6736(93)92876-U
  12. Lee H, Kim J, Lee SY, Park JH, Hwang GS. Processed Panax ginseng, Sun Ginseng, decreases oxidative damage induced by tert-butyl hydroperoxide via regulation of antioxidant enzyme and Anti-apoptotic Molecules in HepG2 Cells. J Ginseng Res. 2012;36:248-255. https://doi.org/10.5142/jgr.2012.36.3.248
  13. Yamabe N, Song KI, Lee W, Han IH, Lee JH, Ham J, Kim SN, Park JH, Kang KS. Chemical and free radical-scavenging activity changes of ginsenoside re by maillard reaction and its possible use as a renoprotective agent. J Ginseng Res. 2012;36: 256-262. https://doi.org/10.5142/jgr.2012.36.2.256
  14. Park JD. Recent studies on the chemical constituents of Korean ginseng (Panax ginseng C.A. Meyer). J Ginseng Res. 1996;20: 389-415.
  15. Kim JH. Protective roles of ginseng saponin in cardiac ischemia and reperfusion injury. J Ginseng Res. 2009;33:283-293. https://doi.org/10.5142/JGR.2009.33.4.283
  16. Massoudy P, Becker BF, Gerlach E. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat. J Cardiovasc Pharmacol. 1994;23:632-639. https://doi.org/10.1097/00005344-199404000-00017
  17. Massoudy P, Beblo S, Raschke P, Zahler S, Becker BF. Influence of intact left atrial appendage on hemodynamic parameters of isolated guinea pig heart. Eur J Med Res. 1998;3: 470-474.
  18. Guo L, Dong Z, Guthrie H. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates. J Pharmacol Toxicol Methods. 2009; 60:130-151. https://doi.org/10.1016/j.vascn.2009.07.002
  19. Minematsu T, Ohtani H, Yamada Y, Sawada Y, Sato H, Iga T. Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/ pharmacodynamic model incorporating a site of adverse effect. J Pharmacokinet Pharmacodyn. 2001;28:533-554. https://doi.org/10.1023/A:1014460404352
  20. Ohtani H, Hanada E, Yamamoto K, Sawada Y, Iga T. Pharmacokinetic- pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats. Biol Pharm Bull. 1996;19:1189-1196. https://doi.org/10.1248/bpb.19.1189
  21. Asha S, Radha E. Effect of age and myocardial infarction on serum and heart lactic dehydrogenase. Exp Gerontol. 1985;20: 67-70. https://doi.org/10.1016/0531-5565(85)90010-5
  22. Gerhardt W, Ljungdahl L, Herbert AK. Troponin-T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992. Clin Biochem. 1993;26:231-240. https://doi.org/10.1016/0009-9120(93)90122-M
  23. Bertinchant JP, Larue C, Pernel I, Ledermann B, Fabbro-Peray P, Beck L, Calzolari C, Trinquier S, Nigond J, Pau B. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem. 1996;29:587-594. https://doi.org/10.1016/S0009-9120(96)00105-1
  24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358. https://doi.org/10.1016/0003-2697(79)90738-3
  25. Beutler E. The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity. J Lab Clin Med. 1957;49:84-95.
  26. Molavi B, Mehta JL. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol. 2004;19:488-493. https://doi.org/10.1097/01.hco.0000133657.77024.bd
  27. Di Meo S, Venditti P, De Leo T. Tissue protection against oxidative stress. Experientia. 1996;52:786-794. https://doi.org/10.1007/BF01923990
  28. Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther. 2001;89:187-206. https://doi.org/10.1016/S0163-7258(00)00114-5
  29. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006;70:181-190. https://doi.org/10.1016/j.cardiores.2006.02.025
  30. Peng Y, Sun Z. Characterization of QT and RR interval series during acute myocardial ischemia by means of recurrence quantification analysis. Med Biol Eng Comput. 2011;49:25-31. https://doi.org/10.1007/s11517-010-0671-5
  31. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods. 1993;30: 55-67. https://doi.org/10.1016/1056-8719(93)90008-3
  32. Robicsek F, Schaper J. Reperfusion injury: fact or myth? J Card Surg. 1997;12:133-137.

Cited by

  1. ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury vol.307, pp.12, 2013, https://doi.org/10.1152/ajpheart.00259.2014
  2. Short-term consumption of Ilex paraguariensis extracts protects isolated hearts from ischemia/reperfusion injury and contradicts exercise-mediated cardioprotection vol.42, pp.11, 2013, https://doi.org/10.1139/apnm-2017-0213
  3. Simulated microgravity increases myocardial susceptibility to ischemia-reperfusion injury via a deficiency of AMP-activated protein kinase vol.95, pp.1, 2013, https://doi.org/10.1139/cjpp-2015-0456
  4. Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action vol.166, pp.None, 2021, https://doi.org/10.1016/j.phrs.2021.105481